U.S. Market for Orthopedic Biomaterials

Date: September 1, 2013
Pages: 273
Price:
US$ 6,995.00
License [?]:
Publisher: iData Research Inc.
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery
ID: U62D0EE016AEN
Leaflet:

Download PDF Leaflet

U.S. Market for Orthopedic Biomaterials
The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems. Conversely, some products that previously experienced rapid market growth have now entered maturity, but even these markets are sustained by continued product evolution.

This comprehensive report critically examines the following market segments: bone graft substitutes, growth factors, orthopedic stem cells, cell therapy, hyaluronic acid viscosupplementation, tendon grafts, cartilage repair and spinal machined bone allografts.

Report Contents:
  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview by Segment
  • Trend Analysis by Segment
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring
The orthopedic biomaterials market has seen movement and reallocation of interests throughout, especially in the cell therapy market. The platelet-rich plasma market has seen a fall in terms of spinal usage. But to counteract this, interest elsewhere, particularly in soft tissue usage, has more than made up for a slowing spinal market segment. As there continues to be more clinical trials for platelet-rich plasma, there will be more varied usage of platelet-rich plasma in non-spinal areas. Currently, there is a lot of interest in soft tissue reconstruction; however, there is still a respectable amount of activity in areas such as joint reconstruction and cardiac surgery. Concentrated bone marrow aspirate has captured the spinal market share lost by platelet-rich plasma and is expected to be the fastest growing segment in the cell therapy market.
EXECUTIVE SUMMARY

1.1 ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW
1.2 ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET
1.3 ORTHOPEDIC GROWTH FACTOR MARKET
1.4 ORTHOPEDIC STEM CELL MARKET
1.5 ORTHOPEDIC CELL THERAPY MARKET
1.6 ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.7 ORTHOPEDIC TENDON GRAFT MARKET
1.8 ORTHOPEDIC CARTILAGE REPAIR MARKET
1.9 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
  Step 1: Project Initiation & Team Selection
  Step 2: Prepare Data Systems and Perform Secondary Research
  Step 3: Preparation for Interviews & Questionnaire Design
  Step 4: Performing Primary Research
  Step 5: Research Analysis: Establishing Baseline Estimates
  Step 6: Market Forecast and Analysis
  Step 7: Identify Strategic Opportunities
  Step 8: Final Review and Market Release
  Step 9: Customer Feedback and Market Monitoring

ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

3.1 INTRODUCTION
  3.1.1 Bone Graft Substitutes
  3.1.2 Growth Factors
  3.1.3 Orthopedic Stem Cell Therapy
  3.1.4 Cell Therapies
  3.1.5 Hyaluronic Acid Viscosupplementation
  3.1.6 Tendon Grafts
  3.1.7 Cartilage Repair
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS
3.4 MARKET DRIVERS AND LIMITERS
  3.4.1 Market Drivers
  3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
  3.5.1 Leading Competitors
3.6 MARKET CONCENTRATION
3.7 MERGERS AND ACQUISITIONS

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET

4.1 INTRODUCTION
4.2 MARKET SEGMENTATION
  4.2.1 By Indication
    4.2.1.1 Spine
    4.2.1.2 Thoracolumbar Spine
    4.2.1.3 Cervical Spine
    4.2.1.4 Trauma
    4.2.1.5 Extremities
  4.2.2 By Material
    4.2.2.1 Autograft
    4.2.2.2 Standard Allograft
    4.2.2.3 Demineralized Bone Matrix
    4.2.2.4 Synthetic
    4.2.2.5 Xenograft
4.3 PROCEDURES
  4.3.1 Bone Graft Substitute Procedures
4.4 UNITS PER PROCEDURE
4.5 MARKET OVERVIEW
  4.5.1 Bone Graft Substitute Market by Material
  4.5.2 Bone Graft Substitute Market by Indication
4.6 MARKET ANALYSIS & FORECAST
  4.6.1 Bone Graft Substitute Market by Material
    4.6.1.1 Total Allograft Bone Graft Substitute Market
    4.6.1.2 Total Demineralized Bone Matrix (DBM) Bone Graft Substitute Market
    4.6.1.3 Total Synthetic Bone Graft Substitute Market
  4.6.2 Bone Graft Substitute Market by Indication
    4.6.2.1 Spine Bone Graft Substitute Market
    4.6.2.2 Cervical Spine Bone Graft Substitute Market
    4.6.2.3 Thoracolumbar Spine Bone Graft Substitute Market
    4.6.2.4 Trauma Bone Graft Substitute Market
    4.6.2.5 Non-union Trauma Fracture Bone Graft Substitute Market
    4.6.2.6 Fresh Fracture Trauma Bone Graft Substitute Market
    4.6.2.7 Large Joint Reconstruction Bone Graft Substitute Market
    4.6.2.8 Hip Large Joint Reconstruction Bone Graft Substitute Market
    4.6.2.9 Knee Large Joint Reconstruction Bone Graft Substitute Market
    4.6.2.10 Foot Reconstruction Bone Graft Substitute Market
    4.6.2.11 Craniomaxillofacial Bone Graft Substitute Market
    4.6.2.12 Oncology Bone Graft Substitute Market
4.7 MARKET DRIVERS AND LIMITERS
  4.7.1 Market Drivers
    4.7.1.1 Allograft Bone Graft Substitute Market
    4.7.1.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market
    4.7.1.3 Synthetic Bone Graft Substitute Market
  4.7.2 Market Limiters
    4.7.2.1 Allograft Bone Graft Substitute Market
    4.7.2.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market
    4.7.2.3 Synthetic Bone Graft Substitute Market
4.8 COMPETITIVE ANALYSIS
  4.8.1 Allograft Bone Graft Substitute Market
  4.8.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market
  4.8.3 Synthetic Bone Graft Substitute Market
  4.8.4 Total Bone Graft Substitute Market

ORTHOPEDIC GROWTH FACTOR MARKET

5.1 INTRODUCTION
5.2 MARKET OVERVIEW
  5.2.1 BMP-2 (Medtronic)
  5.2.2 BMP-7 (Olympus Biomaterials)
  5.2.3 Reimbursement
  5.2.4 Future Indications
5.3 MARKET ANALYSIS & FORECAST
5.4 MARKET DRIVERS AND LIMITERS
  5.4.1 Market Drivers
  5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS

ORTHOPEDIC STEM CELL MARKET

6.1 INTRODUCTION
6.2 MARKET OVERVIEW
  6.2.1 Lineage
    6.2.1.1 Human Embryonic Stem Cells (hESC)
    6.2.1.2 Mesenchymal Stem Cells (MSC)
  6.2.2 Legislation
  6.2.3 Other Therapeutic Applications
6.3 MARKET ANALYSIS & FORECAST
    6.3.1.1 Lumbar Spine Stem Cell Market
    6.3.1.2 Cervical Spine Stem Cell Market
6.4 DRIVERS AND LIMITERS
  6.4.1 Market Drivers
  6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS

ORTHOPEDIC CELL THERAPY MARKET

7.1 INTRODUCTION
  7.1.1 Platelet-Rich Plasma
  7.1.2 Concentrated Bone Marrow Aspirate
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS & FORECAST
  7.3.1 Platelet-Rich Plasma Market
    7.3.1.1 Spinal Platelet-Rich Plasma Market
    7.3.1.2 Soft Tissue Reconstruction Platelet-Rich Plasma Market
    7.3.1.3 Joint Reconstruction Platelet-Rich Plasma Market
    7.3.1.4 Cardiac Surgery Platelet-Rich Plasma Market
    7.3.1.5 Other Platelet-Rich Plasma Markets
  7.3.2 Orthopedic Concentrated Bone Marrow Aspirate Market
    7.3.2.1 Spine Concentrated Bone Marrow Aspirate Market
    7.3.2.2 Trauma Concentrated Bone Marrow Aspirate Market
    7.3.2.3 Joint Reconstruction Concentrated Bone Marrow Aspirate Market
    7.3.2.4 Other Concentrated Bone Marrow Aspirate Market
7.4 MARKET DRIVERS AND LIMITERS
  7.4.1 Market Drivers
  7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS

ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

8.1 INTRODUCTION
  8.1.1 Benefits of Viscosupplementation
  8.1.2 Synovial Fluid
  8.1.3 Product Types
    8.1.3.1 Single-Injection Products
    8.1.3.2 Three-Injection Cycle Products
    8.1.3.3 Three/Five-Injection Cycle Products
  8.1.4 Reimbursement
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS & FORECAST
  8.3.1 Single-Injection Hyaluronic Acid Viscosupplementation Market
  8.3.2 Three-Injection Hyaluronic Acid Viscosupplementation Market
  8.3.3 Five-Injection Hyaluronic Acid Viscosupplementation Market
8.4 MARKET DRIVERS AND LIMITERS
  8.4.1 Market Drivers
  8.4.2 Market Limiters
8.5 COMPETITIVE ANALYSIS

ORTHOPEDIC TENDON GRAFT MARKET

9.1 INTRODUCTION
9.2 MARKET OVERVIEW
  9.2.1 BTB
  9.2.2 Soft Tissue Grafts
  9.2.3 Allografted Tendons
  9.2.4 Ligament and Tendon Synthetic Grafts
9.3 MARKET ANALYSIS & FORECAST
  9.3.1 ACL/PCL Reconstruction Procedures
  9.3.2 ACL/PCL Allograft Tendon Market
9.4 DRIVERS AND LIMITERS
  9.4.1 Market Drivers
  9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS

ORTHOPEDIC CARTILAGE REPAIR MARKET

10.1 INTRODUCTION
  10.1.1 Anatomy
  10.1.2 Methods for Cartilage Repair
    10.1.2.1 Osteochondral Allograft Transfer
    10.1.2.2 Autologous Chondrocyte Implantation (ACI)
    10.1.2.3 Meniscal Allograft Transplantation
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
  10.3.1 Osteochondral Cartilage Allograft Market
  10.3.2 Meniscal Allograft Market
  10.3.3 Autologous Chondrocyte Implantation Market
10.4 MARKET DRIVERS AND LIMITERS
  10.4.1 Market Drivers
  10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS

SPINAL MACHINED BONE ALLOGRAFT MARKET

11.1 INTRODUCTION
  11.1.1 Machined Bone
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS & FORECAST
  11.3.1 Spinal Machined Bone Allograft Market by Segment
    11.3.1.1 ALIF Machined Bone Allograft Market
    11.3.1.2 PLIF Machined Bone Allograft Market
    11.3.1.3 TLIF Machined Bone Allograft Market
    11.3.1.4 CIF Machined Bone Allograft Market
11.4 MARKET DRIVERS AND LIMITERS
  11.4.1 Market Drivers
  11.4.2 Market Limiters
11.5 COMPETITIVE ANALYSIS

ABBREVIATIONS

LIST OF CHARTS

Chart 1 1: Orthopedic Biomaterials Market, US, 2009 – 2019
Chart 1 2: Orthopedic Bone Graft Substitute Market Shares by Segment, U.S., 2012
Chart 1 3: Growth Rates, Orthopedic Growth Factor Market, U.S., 2009 – 2019
Chart 1 4: Orthopedic Stem Cell Market Shares by Segment, U.S., 2012 and 2019
Chart 1 5: Orthopedic Cell Therapy Market Shares by Segment, U.S., 2009 – 2019
Chart 1 6: Orthopedic Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2009 – 2019
Chart 1 7: ACL/PCL Reconstruction Procedures by Graft Type, U.S., 2009 – 2019
Chart 1 8: Orthopedic Cartilage Repair Market Shares by Segment, U.S., 2012
Chart 1 9: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2012
Chart 3 1: Orthopedic Biomaterials Market by Segment, U.S., 2009 – 2019
Chart 3 2: Orthopedic Biomaterials Market Breakdown by Segment, U.S., 2012
Chart 3 3: Orthopedic Biomaterials Market Breakdown by Segment, U.S., 2019
Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, U.S., 2009 – 2019
Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2012
Chart 3 6: Herfindahl Index, Orthopedic Biomaterials Market, U.S., 2012
Chart 4 1: Bone Graft Substitute Procedures, U.S., 2009 – 2019
Chart 4 2: Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 3: Bone Graft Substitute Market by Material, U.S., 2009 – 2019
Chart 4 4: Bone Graft Substitute Market Breakdown by Material, U.S., 2012
Chart 4 5: Bone Graft Substitute Market Breakdown by Material, U.S., 2019
Chart 4 6: Bone Graft Substitute Market by Indication, U.S., 2009 – 2019
Chart 4 7: Bone Graft Substitute Market Breakdown by Indication, U.S., 2012
Chart 4 8: Bone Graft Substitute Market Breakdown by Indication, U.S., 2019
Chart 4 9: Allograft Bone Graft Substitute Market by Indication, U.S., 2009 – 2019
Chart 4 10: Spine Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 11: Cervical Spine Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 12: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 13: Trauma Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 14: Non-union Trauma Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 15: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 16: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 17: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 18: Knee Reconstruction Allograft Graft Substitute Market, U.S., 2009 – 2019
Chart 4 19: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 20: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 21: Oncology Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 22: Total DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 23: DBM Bone Graft Substitute Market by Indication, U.S., 2009 – 2019
Chart 4 24: Spine DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 25: Cervical Spine DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 26: Thoracolumbar Spine DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 27: Trauma DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 28: Non-union Trauma DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 29: Fresh Fracture Trauma DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 30: Large Joint Reconstruction DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 31: Hip Large Joint Reconstruction DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 32: Knee Large Joint Reconstruction DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 33: Foot Reconstruction DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 34: Craniomaxillofacial DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 35: Oncology DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 36: Synthetic Bone Graft Substitute Market by Segment, U.S., 2009 – 2019
Chart 4 37: Spine Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 38: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 39: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 40: Trauma Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 41: Non-union Trauma Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 42: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 43: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 44: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 45: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 46: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 47: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 48: Oncology Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 49: Spine Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 50: Cervical Spine Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 51: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 52: Trauma Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 53: Non-union Trauma Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 54: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 55: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 56: Hip Reconstruction Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 57: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 58: Foot Reconstruction Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 59: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 60: Oncology Bone Graft Substitute Market, U.S., 2009 – 2019
Chart 4 61: Leading Competitors, Allograft Bone Graft Substitute Market, U.S., 2012
Chart 4 62: Leading Competitors, DBM Bone Graft Substitute Market, U.S., 2012
Chart 4 63: Leading Competitors, Synthetics Bone Graft Substitute Market, U.S., 2012
Chart 4 64: Leading Competitors, Total Bone Graft Substitute Market, U.S., 2012
Chart 5 1: Orthopedic Growth Factor Market, U.S., 2009 – 2019
Chart 5 2: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2012
Chart 6 1: Orthopedic Stem Cell Market, U.S., 2009 – 2019
Chart 6 2: Orthopedic Stem Cell Market by Indication, U.S., 2009 – 2019
Chart 6 3: Orthopedic Stem Cell Market Breakdown by Indication, U.S., 2012
Chart 6 4: Orthopedic Stem Cell Market Breakdown by Indication, U.S., 2019
Chart 6 5: Lumbar Spine Stem Cell Market, U.S., 2009 – 2019
Chart 6 6: Cervical Spine Stem Cell Market, U.S., 2009 – 2019
Chart 6 7: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2012
Chart 7 1: Total Orthopedic Cell Therapy Market, U.S., 2009 – 2019
Chart 7 2: Orthopedic Cell Therapy Market by Segment, U.S., 2009 – 2019
Chart 7 3: Orthopedic Cell Therapy Market Breakdown by Segment, U.S., 2009
Chart 7 4: Orthopedic Cell Therapy Market Breakdown by Segment, U.S., 2019
Chart 7 5: Total Platelet-Rich Plasma Market, U.S., 2009 – 2019
Chart 7 6: Platelet-Rich Plasma Market by Segment, U.S., 2009 – 2019
Chart 7 7: Platelet-Rich Plasma Market Breakdown by Segment, U.S., 2012
Chart 7 8: Platelet-Rich Plasma Market Breakdown by Segment, U.S., 2019
Chart 7 9: Spinal Platelet-Rich Plasma Market, U.S., 2009 – 2019
Chart 7 10: Soft Tissue Reconstruction Platelet-Rich Plasma Market, U.S., 2009 – 2019
Chart 7 11: Joint Reconstruction Platelet-Rich Plasma Market, U.S., 2009 – 2019
Chart 7 12: Cardiac Surgery Platelet-Rich Plasma Market, U.S., 2009 – 2019
Chart 7 13: Other Platelet-Rich Plasma Market, U.S., 2009 – 2019
Chart 7 14: Total Orthopedic Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Chart 7 15: Orthopedic Concentrated Bone Marrow Aspirate Market by Segment, U.S., 2009 – 2019
Chart 7 16: Orthopedic Concentrated Bone Marrow Aspirate Market Breakdown by Segment, U.S., 2012
Chart 7 17: Orthopedic Concentrated Bone Marrow Aspirate Market Breakdown by Segment, U.S., 2019
Chart 7 18: Spine Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Chart 7 19: Trauma Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Chart 7 20: Joint Reconstruction Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Chart 7 21: Other Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Chart 7 22: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2012
Chart 8 1: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2009 – 2019
Chart 8 2: Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2009 – 2019
Chart 8 3: Hyaluronic Acid Viscosupplementation Market Brrakdown by Segment, U.S., 2012
Chart 8 4: Hyaluronic Acid Viscosupplementation Market Breakdown by Segment, U.S., 2019
Chart 8 5: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2009 – 2019
Chart 8 6: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2009 – 2019
Chart 8 7: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2009 – 2019
Chart 8 8: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2012
Chart 9 1: ACL/PCL Reconstruction Procedure Breakdown by Graft Type, U.S., 2012
Chart 9 2: ACL/PCL Reconstruction Procedure Breakdown by Graft Type, U.S., 2019
Chart 9 3: ACL/PCL Allograft Tendon Market, U.S., 2009 – 2019
Chart 9 4: Leading Competitors, Orthopedic Tendon Graft Market, U.S., 2012
Chart 10 1: Total Orthopedic Cartilage Repair Market, U.S., 2009 – 2019
Chart 10 2: Orthopedic Cartilage Repair Market by Segment, U.S., 2009 – 2019
Chart 10 3: Orthopedic Cartilage Repair Market Breakdown by Segment, U.S., 2012
Chart 10 4: Orthopedic Cartilage Repair Market Breakdown by Segment, U.S., 2019
Chart 10 5: Osteochondral Cartilage Allograft Market, U.S., 2009 – 2019
Chart 10 6: Meniscal Allograft Market, U.S., 2009 – 2019
Chart 10 7: Autologous Chondrocyte Implantation Market, U.S., 2009 – 2019
Chart 10 8: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2012
Chart 11 1: Spinal Machined Bone Allograft Market by Segment, U.S., 2009 – 2019
Chart 11 2: Spinal Machined Bone Allograft Market Breakdown by Segment, U.S., 2012
Chart 11 3: Spinal Machined Bone Allograft Market Breakdown by Segment, U.S., 2019
Chart 11 4: ALIF Machined Bone Allograft Market, U.S., 2009 – 2019
Chart 11 5: PLIF Machined Bone Allograft Market, U.S., 2009 – 2019
Chart 11 6: TLIF Machined Bone Allograft Market, U.S., 2009 – 2019
Chart 11 7: CIF Machined Bone Allograft Market, U.S., 2009 – 2019
Chart 11 8: Leading Competitors, Interbody Device Market, U.S., 2012

LIST OF FIGURES

Figure 3 1: Orthopedic Biomaterials Market by Segment, U.S., 2009 – 2019 (US$M)
Figure 3 2: Growth Rates by Segment, Orthopedic Biomaterials Market, U.S., 2009 – 2019
Figure 3 3: Drivers and Limiters, Orthopedic Biomaterials Market, U.S., 2012
Figure 3 4: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2012 (Part 1 of 2)
Figure 3 5: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2012 (Part 2 of 2)
Figure 3 6: Herfindahl Index, Orthopedic Biomaterials Market, U.S., 2012
Figure 4 1: Bone Graft Substitute Procedures, U.S., 2009 – 2019
Figure 4 2: Units per Procedure by Indication, Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 3: Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 4: Bone Graft Substitute Market by Material, U.S., 2009 – 2019 (US$M)
Figure 4 5: Bone Graft Substitute Market by Indication, U.S., 2009 – 2019 (US$M)
Figure 4 6: Total Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 7: Allograft Bone Graft Substitute Market by Indication, U.S., 2009 – 2019 (US$M)
Figure 4 8: Spine Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 9: Cervical Spine Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 10: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 11: Trauma Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 12: Non-union Trauma Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 13: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 14: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 15: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 16: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 17: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 18: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 19: Oncology Allograft Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 20: Total DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 21: Total DBM Bone Graft Substitutes with Carriers Market, U.S., 2009 – 2019
Figure 4 22: Total DBM Bone Graft Substitutes without Carriers Market, U.S., 2009 – 2019
Figure 4 23: DBM Bone Graft Substitute Market by Indication, U.S., 2009 – 2019 (US$M)
Figure 4 24: Spine DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 25: Cervical Spine DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 26: Thoracolumbar Spine DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 27: Trauma DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 28: Non-union Trauma DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 29: Fresh Fracture Trauma DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 30: Large Joint Reconstruction DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 31: Hip Large Joint Reconstruction DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 32: Knee Large Joint Reconstruction DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 33: Foot Reconstruction DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 34: Craniomaxillofacial DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 35: Oncology DBM Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 36: Total Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 37: Synthetic Bone Graft Substitute Market by Segment, U.S., 2009 – 2019 (US$M)
Figure 4 38: Spine Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 39: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 40: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 41: Trauma Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 42: Non-union Trauma Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 43: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 44: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 45: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 46: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 47: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 48: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 49: Oncology Synthetic Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 50: Spine Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 51: Cervical Spine Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 52: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 53: Trauma Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 54: Non-union Trauma Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 55: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 56: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 57: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 58: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 59: Foot Reconstruction Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 60: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 61: Oncology Bone Graft Substitute Market, U.S., 2009 – 2019
Figure 4 62: Drivers and Limiters, Orthopedic Bone Graft Substitute Market, U.S., 2012
Figure 4 63: Leading Competitors, Allograft Bone Graft Substitute Market, U.S., 2012
Figure 4 64: Leading Competitors, DBM Bone Graft Substitute Market, U.S., 2012
Figure 4 65: Leading Competitors, Synthetic Bone Graft Substitute Market, U.S., 2012
Figure 4 66: Leading Competitors, Total Orthopedic Bone Graft Substitute Market, U.S., 2012
Figure 5 1: Orthopedic Growth Factor Market, U.S., 2009 – 2019
Figure 5 2: Drivers and Limiters, Orthopedic Growth Factor Market, U.S., 2012
Figure 5 3: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2012
Figure 6 1: Orthopedic Stem Cell Market, U.S., 2009 – 2019
Figure 6 2: Orthopedic Stem Cell Market by Indication, U.S., 2009 – 2019 (US$M)
Figure 6 3: Lumbar Spine Stem Cell Market, U.S., 2009 – 2019
Figure 6 4: Cervical Spine Stem Cell Market, U.S., 2009 – 2019
Figure 6 5: Drivers and Limiters, Orthopedic Stem Cell Market, US, 2012
Figure 6 6: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2012
Figure 7 1: Total Orthopedic Cell Therapy Market, U.S., 2009 – 2019
Figure 7 2: Orthopedic Cell Therapy Market by Segment, U.S., 2009 – 2019 (US$M)
Figure 7 3: Total Platelet-Rich Plasma Market, U.S., 2009 – 2019
Figure 7 4: Platelet-Rich Plasma Market By Segment, U.S., 2009 – 2019 (US$M)
Figure 7 5: Spinal Platelet-Rich Plasma Market, U.S., 2009 – 2019
Figure 7 6: Soft Tissue Reconstruction Platelet-Rich Plasma Market, U.S., 2009 – 2019
Figure 7 7: Joint Reconstruction Platelet-Rich Plasma Market, U.S., 2009 – 2019
Figure 7 8: Cardiac Surgery Platelet-Rich Plasma Market, U.S., 2009 – 2019
Figure 7 9: Other Platelet-Rich Plasma Market, U.S., 2009 – 2019
Figure 7 10: Total Orthopedic Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Figure 7 11: Orthopedic Concentrated Bone Marrow Aspirate Market by Segment, U.S., 2009 – 2019 (US$M)
Figure 7 12: Spine Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Figure 7 13: Trauma Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Figure 7 14: Joint Reconstruction Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Figure 7 15: Other Concentrated Bone Marrow Aspirate Market, U.S., 2009 – 2019
Figure 7 16: Drivers and Limiters, Orthopedic Cell Therapy Market, U.S., 2012
Figure 7 17: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2012
Figure 8 1: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2009 – 2019
Figure 8 2: Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2009 – 2019 (US$M)
Figure 8 3: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2009 – 2019
Figure 8 4: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2009 – 2019
Figure 8 5: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2009 – 2019
Figure 8 6: Drivers and Limiters, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2012
Figure 9 1: ACL/PCL Reconstruction Procedures by Graft Type, U.S., 2009 – 2019
Figure 9 2: ACL/PCL Allograft Tendon Market, U.S., 2009 – 2019
Figure 9 3: Drivers and Limiters, Orthopedic Tendon Graft Market, U.S., 2012
Figure 9 4: Leading Competitors, Orthopedic Tendon Graft Market, U.S., 2012
Figure 10 1: Total Orthopedic Cartilage Repair Market, U.S., 2009 – 2019
Figure 10 2: Orthopedic Cartilage Repair Market by Segment, U.S., 2009 – 2019 (US$M)
Figure 10 3: Osteochondral Cartilage Allograft Market, U.S., 2009 – 2019
Figure 10 4: Meniscal Allograft Market, U.S., 2009 – 2019
Figure 10 5: Autologous Chondrocyte Implantation Market, U.S., 2009 – 2019
Figure 10 6: Drivers and Limiters, Orthopedic Cartilage Repair Market, U.S., 2012
Figure 10 7: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2012
Figure 11 1: Spinal Machined Bone Allograft Market by Segment, U.S., 2009 – 2019 (US$M)
Figure 11 2: ALIF Machined Bone Allograft Market, U.S., 2009 – 2019
Figure 11 3: PLIF Machined Bone Allograft Market, U.S., 2009 – 2019
Figure 11 4: TLIF Machined Bone Allograft Market, U.S., 2009 – 2019
Figure 11 5: CIF Machined Bone Allograft Market, U.S., 2009 – 2019
Figure 11 6: Drivers and Limiters, Spinal Machined Bone Allograft Market, U.S., 2012
Figure 11 7: Leading Competitors, Spinal Machined Bone Allograft Market, U.S., 2012
Skip to top


European Markets for Orthopedic Biomaterials US$ 8,995.00 Nov, 2013 · 328 pages
Orthopedic Biomaterials, The World Market US$ 3,995.00 May, 2011 · 250 pages
Global Biomaterial Market (2009-2014) US$ 5,650.00 Sep, 2009 · 256 pages
Brazil Biomaterial Market (2010 – 2015) US$ 5,650.00 May, 2011 · 179 pages

Ask Your Question

U.S. Market for Orthopedic Biomaterials
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: